ocrelizumab,dimethyl fumarate
roche,biogen
['cello']
can ms be prevented by treating it in the subclinical/prodromal (before characteristic symptoms) phase? trials mentioned during evolving the paradigm of patient care in ms and forging a path ahead (cello, teris and arise) aim to explore just that. #ectrims2022